Definitive biopsy with immunohistochemistry confirmed a high-grade B-cell lymphoma, positive for CD5 and demonstrating triple expression of Bcl2, Bcl6, and c-Myc. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.